What is Hyzaar? Hyzaar (Losartan And Hydrochlorothiazide) is an angiotensin II receptor antagonist used to treat high blood pressure by working to prevent the narrowing of blood vessels. Losartan is used to treat diabetic kidney problems as well. Your pharmacist may know of alternate uses for Hyzaar (Losartan And Hydrochlorothiazide). Click for more Hyzaar details.
What is Generic Hyzaar?
Generic Hyzaar, like all generics, is the name given to the
prescription Losartan and Hydrochlorothiazide medication manufactured by any company other than the
original inventor of Hyzaar. The only true difference between brand name Hyzaar
and generic Hyzaar is that generic Hyzaar is always less expensive.
Also known as: Cozaar-H, Fortzaar, Losartan And Hydrochlorothiazide (generic name).
Generic Hyzaar is at OpenRxShop
|*** SAVE 5% to 10% MORE WITH DISCOUNT COUPON: MAvU6EZMU3 ***|
|Hyzaar Losartan Potassium /Hydrochlorothiazide 12.5mg Pills (Generic)||50mg||30 ||$91.00||Order|
|Hyzaar Losartan Potassium /Hydrochlorothiazide 12.5mg Pills (Generic)||50mg||60 ||$126.00||Order|
|Hyzaar Losartan Potassium /Hydrochlorothiazide 12.5mg Pills (Generic)||50mg||90 ||$150.00||Order|
Hyzaar is at EuroPharma365
|*** ACCEPTS ALL MAJOR CREDIT CARDS: VISA, MASTERCARD, AMEX ***|
|Hyzaar||25 mg||30 pills||$169.41||Order|
|Hyzaar||25 mg||60 pills||$222.68||Order|
|Hyzaar||25 mg||90 pills||$244.00||Order|
|Hyzaar||25 mg||120 pills||$286.62||Order|
|Hyzaar||25 mg||180 pills||$318.58||Order|
|Hyzaar||50 mg||30 pills||$212.03||Order|
|Hyzaar||50 mg||60 pills||$265.31||Order|
|Hyzaar||50 mg||90 pills||$318.58||Order|
|Hyzaar||50 mg||120 pills||$361.20||Order|
|Hyzaar||50 mg||180 pills||$425.13||Order|
Buy Generic Hyzaar - No Prior Prescription Needed*
How To Buy Generic Hyzaar Online
Buy discount generic Hyzaar (Losartan and Hydrochlorothiazide) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Hyzaar - Health Bulletin
Post-Chemo Treatment May Boost Lung Cancer Survival
THURSDAY, May 20 (HealthDay News) -- Among people with non-small-cell lung cancer, treatment with the drug erlotinib (Tarceva) after chemotherapy appears to slightly boost survival rates, a new study suggests.
Non-small-cell lung cancer makes up about 85% of lung cancer cases. About half the time, people have advanced disease when diagnosed and are treated solely with chemotherapy, usually platinum-based chemo. But chemotherapy only boosts survival by eight to 10 months, the study authors noted.Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.